NSE:REMUS

REMUS PHARMACEUTICALS L

₹875.00
at close · 29 Oct 2026
▼ 4.00 (-0.46%)

Latest filings

Next results: Tue, 3 Nov · Financial Results/Dividend/Other business matters
  1. Remus Pharma schedules H1 FY2027 earnings call for November 4, 2026 · Board & Shareholder Meetings
  2. Quarterly share capital audit report filed for September 2026 · Compliance
  3. Routine compliance filing for Q2 FY27 share dematerialisation certificate · Compliance
All filings ↓
Ask Nexa about REMUS PHARMACEUTICALS L

Snapshot

What the business is, and whether it's a good one at a fair price.

A listed company listed on NSE.

Market Cap
₹1,031 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
0.11%
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
14.1%▲
ROCE (FY26)
ROE 11.9% · margin 7.4%
Leverage
0.06·
Debt / Equity · low
Net debt ₹11 Cr
Moves on a normal day
2.01%·
Median daily move
Last 262 sessions · the yardstick for filing-day moves

Scorecard

Measured from the filed financials · as of FY26 — not investment advice

Strengths
Debt at 0.06× equity
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

REMUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from REMUS PHARMACEUTICALS L's filed financials and exchange disclosures

What does REMUS PHARMACEUTICALS L do?

REMUS PHARMACEUTICALS L is listed on NSE, trading under the symbol REMUS.

Does REMUS PHARMACEUTICALS L pay a dividend?

Yes. The dividend yield is 0.11% at the current price. It paid out 3% of its profit as dividend in FY26.

Is REMUS PHARMACEUTICALS L debt-free?

No. It reported borrowings of ₹23 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹11 Cr after cash. Debt stands at 0.06× equity.

How much does the REMUS PHARMACEUTICALS L share price move in a day?

On a typical session REMUS PHARMACEUTICALS L moves 2.01% — that is the median absolute close-to-close move across its last 262 trading days. MarketPing measures each filing's price reaction against it.

When are REMUS PHARMACEUTICALS L's next results?

Financial Results/Dividend/Other business matters on Tue, 3 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track REMUS PHARMACEUTICALS L's announcements?

Every NSE and BSE filing by REMUS PHARMACEUTICALS L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.